258 related articles for article (PubMed ID: 22934582)
1. Analysis of current antifungal agents and their targets within the Pneumocystis carinii genome.
Porollo A; Meller J; Joshi Y; Jaiswal V; Smulian AG; Cushion MT
Curr Drug Targets; 2012 Nov; 13(12):1575-85. PubMed ID: 22934582
[TBL] [Abstract][Full Text] [Related]
2. Sterol biosynthesis and sterol uptake in the fungal pathogen Pneumocystis carinii.
Joffrion TM; Cushion MT
FEMS Microbiol Lett; 2010 Oct; 311(1):1-9. PubMed ID: 20528942
[TBL] [Abstract][Full Text] [Related]
3. Are cytochrome b gene mutations the only cause of atovaquone resistance in Pneumocystis?
Kaneshiro ES
Drug Resist Updat; 2001 Oct; 4(5):322-9. PubMed ID: 11991686
[TBL] [Abstract][Full Text] [Related]
4. Splenic pneumocystosis: an atypical presentation of extrapulmonary Pneumocystis infection.
O'Neal CB; Ball SC
AIDS Read; 2008 Oct; 18(10):503-8. PubMed ID: 18975440
[No Abstract] [Full Text] [Related]
5. Comparative genomics of pneumocystis species suggests the absence of genes for myo-inositol synthesis and reliance on inositol transport and metabolism.
Porollo A; Sesterhenn TM; Collins MS; Welge JA; Cushion MT
mBio; 2014 Nov; 5(6):e01834. PubMed ID: 25370490
[TBL] [Abstract][Full Text] [Related]
6. Identification and Functional Ascertainment of the Pneumocystis jirovecii Potential Drug Targets Gsc1 and Kre6 Involved in Glucan Synthesis.
Luraschi A; Cissé OH; Pagni M; Hauser PM
J Eukaryot Microbiol; 2017 Jul; 64(4):481-490. PubMed ID: 27859907
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of Pneumocystis to echinocandins in suspension and biofilm cultures.
Cushion MT; Collins MS
Antimicrob Agents Chemother; 2011 Oct; 55(10):4513-8. PubMed ID: 21788469
[TBL] [Abstract][Full Text] [Related]
8. Site-Directed Mutagenesis of the 1,3-β-Glucan Synthase Catalytic Subunit of
Luraschi A; Richard S; Hauser PM
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30249686
[TBL] [Abstract][Full Text] [Related]
9. Transcriptome of Pneumocystis carinii during fulminate infection: carbohydrate metabolism and the concept of a compatible parasite.
Cushion MT; Smulian AG; Slaven BE; Sesterhenn T; Arnold J; Staben C; Porollo A; Adamczak R; Meller J
PLoS One; 2007 May; 2(5):e423. PubMed ID: 17487271
[TBL] [Abstract][Full Text] [Related]
10. Enhanced pneumocystis carinii activity of new primaquine analogues.
Goodwin TE; Boylan CJ; Current WL; Byrd JC; Edwards CB; Fuller DA; Green JL; Larocca CD; Raney KD; Ross AS; Tucker WA
Bioorg Med Chem Lett; 2000 Oct; 10(19):2205-8. PubMed ID: 11012030
[TBL] [Abstract][Full Text] [Related]
11. [Pneumocystis pneumonia in newborns: a challenge in contemporary intensive care].
Kordek A; Kołodziejczyk L; Pawlus B; Łoniewska B; Kuźna-Grygiel W; Rudnicki J
Ann Acad Med Stetin; 2006; 52(2):65-70; discussion 70. PubMed ID: 17633398
[TBL] [Abstract][Full Text] [Related]
12. Progression of Pneumocystis jiroveci pneumonia in patients receiving echinocandin therapy.
Kamboj M; Weinstock D; Sepkowitz KA
Clin Infect Dis; 2006 Nov; 43(9):e92-4. PubMed ID: 17029129
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of caspofungin, a 1,3-β-D-glucan synthase inhibitor, on Pneumocystis carinii pneumonia in rats.
Sun P; Tong Z
Med Mycol; 2014 Nov; 52(8):798-803. PubMed ID: 25288652
[TBL] [Abstract][Full Text] [Related]
14. Pneumocystis jiroveci dihydropteroate synthase gene mutations among colonized individuals and Pneumocystis pneumonia patients from Spain.
Friaza V; Morilla R; Respaldiza N; de la Horra C; Calderón EJ
Postgrad Med; 2010 Nov; 122(6):24-8. PubMed ID: 21084778
[TBL] [Abstract][Full Text] [Related]
15. SYTO-13, a Viability Marker as a New Tool to Monitor In Vitro Pharmacodynamic Parameters of Anti-Pneumocystis Drugs.
Standaert-Vitse A; Aliouat-Denis CM; Martinez A; Khalife S; Pottier M; Gantois N; Dei-Cas E; Aliouat el M
PLoS One; 2015; 10(6):e0130358. PubMed ID: 26103633
[TBL] [Abstract][Full Text] [Related]
16. Absence of dihydropteroate synthase gene mutations in Pneumocystis jirovecii strains isolated from Aegean region of Turkey.
Ozkoc S; Erguden C; Bayram Delibas S
Parasitol Res; 2018 Oct; 117(10):3103-3108. PubMed ID: 30027382
[TBL] [Abstract][Full Text] [Related]
17. Novel dihydropteroate synthase gene mutation in Pneumocystis jirovecii among HIV-infected patients in India: Putative association with drug resistance and mortality.
Singh Y; Mirdha BR; Guleria R; Kabra SK; Mohan A; Chaudhry R; Kumar L; Dwivedi SN; Agarwal SK
J Glob Antimicrob Resist; 2019 Jun; 17():236-239. PubMed ID: 30658203
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review.
Huang YS; Yang JJ; Lee NY; Chen GJ; Ko WC; Sun HY; Hung CC
Expert Rev Anti Infect Ther; 2017 Sep; 15(9):873-892. PubMed ID: 28782390
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and tolerability of intravenous pentamidine for Pneumocystis carinii pneumonia prophylaxis in adult hematopoietic stem cell transplant patients: a retrospective study.
Awad WB; Asaad A; Al-Yasein N; Najjar R
BMC Infect Dis; 2020 Jun; 20(1):400. PubMed ID: 32503449
[TBL] [Abstract][Full Text] [Related]
20. Genomic insights into the host specific adaptation of the Pneumocystis genus.
Cissé OH; Ma L; Dekker JP; Khil PP; Youn JH; Brenchley JM; Blair R; Pahar B; Chabé M; Van Rompay KKA; Keesler R; Sukura A; Hirsch V; Kutty G; Liu Y; Peng L; Chen J; Song J; Weissenbacher-Lang C; Xu J; Upham NS; Stajich JE; Cuomo CA; Cushion MT; Kovacs JA
Commun Biol; 2021 Mar; 4(1):305. PubMed ID: 33686174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
